Representatives of the government and the pharmaceutical industry met at CII’s 12th National Pharmaceutical Conclave, recently, to discuss ways of addressing India’s national health challenges. There was consensus within the industry that the ‘time is now’ to convert intent into action.
Strengthening regulatory oversight will set India on the path to faster growth, accelerate new drug approvals and give a boost to ambitious initiatives such as Make in India.
Did you know?